These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 37436574)
21. Prognostic value of the Oxford classification and the Oxford score in IgA nephropathy: A Tunisian study. Jebali H; Ghabi H; Mami I; Kaab BB; Fatma LB; Smaoui W; Haouet S; Mahjouba HB; Hassan M; Hmida FB; Raies L; Zouaghi MK Saudi J Kidney Dis Transpl; 2020; 31(6):1366-1375. PubMed ID: 33565449 [TBL] [Abstract][Full Text] [Related]
22. Risk factors for progression in children and young adults with IgA nephropathy: an analysis of 261 cases from the VALIGA European cohort. Coppo R; Lofaro D; Camilla RR; Bellur S; Cattran D; Cook HT; Roberts IS; Peruzzi L; Amore A; Emma F; Fuiano L; Berg U; Topaloglu R; Bilginer Y; Gesualdo L; Polci R; Mizerska-Wasiak M; Caliskan Y; Lundberg S; Cancarini G; Geddes C; Wetzels J; Wiecek A; Durlik M; Cusinato S; Rollino C; Maggio M; Praga M; K Smerud H; Tesar V; Maixnerova D; Barratt J; Papalia T; Bonofiglio R; Mazzucco G; Giannakakis C; Soderberg M; Orhan D; Di Palma AM; Maldyk J; Ozluk Y; Sudelin B; Tardanico R; Kipgen D; Steenbergen E; Karkoszka H; Perkowska-Ptasinska A; Ferrario F; Gutierrez E; Honsova E Pediatr Nephrol; 2017 Jan; 32(1):139-150. PubMed ID: 27557557 [TBL] [Abstract][Full Text] [Related]
23. Arteriolar C4d in IgA Nephropathy: A Cohort Study. Faria B; Canão P; Cai Q; Henriques C; Matos AC; Poppelaars F; Gaya da Costa M; Daha MR; Silva R; Pestana M; Seelen MA Am J Kidney Dis; 2020 Nov; 76(5):669-678. PubMed ID: 32439421 [TBL] [Abstract][Full Text] [Related]
24. Is it possible to predict the evolution of IgAN? Validation of the IgA nephropathy progression calculator and its relationship with MEST-C score in our population. Martín-Penagos L; Benito A; Oviedo MV; López Del Moral Cuesta C; Martín López J; Gómez Román J; López-Mejías R; Fernandez-Fresnedo G; Ruíz San Millán JC; Rodrigo Calabia E Nefrologia (Engl Ed); 2019; 39(5):523-530. PubMed ID: 30902505 [TBL] [Abstract][Full Text] [Related]
25. Development and validation of a diagnostic nomogram to evaluate tubular atrophy/interstitial fibrosis of IgA nephropathy. Gan Y; Cai Y; Li J; Wu J; Zhang R; Han Q; Li W; Yang Q Int J Med Sci; 2024; 21(4):674-680. PubMed ID: 38464822 [No Abstract] [Full Text] [Related]
26. Clinical and prognostic significance of C1q deposition in IgAN patients-a retrospective study. Tian S; Yang X; Luo J; Guo H Int Immunopharmacol; 2020 Nov; 88():106896. PubMed ID: 33182045 [TBL] [Abstract][Full Text] [Related]
27. The Oxford Classification predictors of chronic kidney disease in pediatric patients with IgA nephropathy. Fabiano RCG; Araújo SA; Bambirra EA; Oliveira EA; Simões E Silva AC; Pinheiro SVB J Pediatr (Rio J); 2017; 93(4):389-397. PubMed ID: 28130969 [TBL] [Abstract][Full Text] [Related]
28. Relationship between serum IgA/C3 ratio and severity of histological lesions using the Oxford classification in children with IgA nephropathy. Mizerska-Wasiak M; Małdyk J; Rybi-Szumińska A; Wasilewska A; Miklaszewska M; Pietrzyk J; Firszt-Adamczyk A; Stankiewicz R; Bieniaś B; Zajączkowska M; Gadomska-Prokop K; Grenda R; Pukajło-Marczyk A; Zwolińska D; Szczepańska M; Turczyn A; Roszkowska-Blaim M Pediatr Nephrol; 2015 Jul; 30(7):1113-20. PubMed ID: 25549975 [TBL] [Abstract][Full Text] [Related]
29. A validation study of crescents in predicting ESRD in patients with IgA nephropathy. Zhang X; Shi S; Ouyang Y; Yang M; Shi M; Pan X; Lv J; Wang Z; Ren H; Shen P; Wang W; Zhang H; Xie J; Chen N J Transl Med; 2018 May; 16(1):115. PubMed ID: 29724226 [TBL] [Abstract][Full Text] [Related]
30. Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments. Coppo R; Troyanov S; Bellur S; Cattran D; Cook HT; Feehally J; Roberts IS; Morando L; Camilla R; Tesar V; Lunberg S; Gesualdo L; Emma F; Rollino C; Amore A; Praga M; Feriozzi S; Segoloni G; Pani A; Cancarini G; Durlik M; Moggia E; Mazzucco G; Giannakakis C; Honsova E; Sundelin BB; Di Palma AM; Ferrario F; Gutierrez E; Asunis AM; Barratt J; Tardanico R; Perkowska-Ptasinska A; Kidney Int; 2014 Oct; 86(4):828-36. PubMed ID: 24694989 [TBL] [Abstract][Full Text] [Related]
31. Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group. Trimarchi H; Barratt J; Cattran DC; Cook HT; Coppo R; Haas M; Liu ZH; Roberts IS; Yuzawa Y; Zhang H; Feehally J; ; Kidney Int; 2017 May; 91(5):1014-1021. PubMed ID: 28341274 [TBL] [Abstract][Full Text] [Related]
32. Endotrophin, a collagen type VI-derived matrikine, reflects the degree of renal fibrosis in patients with IgA nephropathy and in patients with ANCA-associated vasculitis. Sparding N; Genovese F; Rasmussen DGK; Karsdal MA; Neprasova M; Maixnerova D; Satrapova V; Frausova D; Hornum M; Bartonova L; Honsova E; Kollar M; Koprivova H; Hruskova Z; Tesar V Nephrol Dial Transplant; 2022 May; 37(6):1099-1108. PubMed ID: 33914059 [TBL] [Abstract][Full Text] [Related]
33. Role of tubulointerstitial plasmin in the progression of IgA nephropathy. Uchida T; Oda T; Takechi H; Matsubara H; Watanabe A; Yamamoto K; Oshima N; Sakurai Y; Kono T; Shimazaki H; Tamai S; Kumagai H J Nephrol; 2016 Feb; 29(1):53-62. PubMed ID: 25971850 [TBL] [Abstract][Full Text] [Related]
34. Time series changes in pseudo-R2 values regarding maximum glomerular diameter and the Oxford MEST-C score in patients with IgA nephropathy: A long-term follow-up study. Kataoka H; Ohara M; Suzuki T; Inoue T; Akanuma T; Kawachi K; Manabe S; Ushio Y; Kawasoe K; Akihisa T; Sato M; Iwasa N; Sawara Y; Honda K; Mochizuki T; Tsuchiya K; Nitta K PLoS One; 2020; 15(5):e0232885. PubMed ID: 32379841 [TBL] [Abstract][Full Text] [Related]
35. Value of urinary levels of interleukin-6, epidermal growth factor, monocyte chemoattractant protein type1 and transforming growth factor β1 in predicting the extent of fibrosis lesions in kidney biopsies of patients with IgA nephropathy. Segarra-Medrano A; Carnicer-Caceres C; Valtierra-Carmeno N; Agraz-Pamplona I; Ramos-Terrades N; Jatem Escalante E; Ostos-Roldan E Nefrologia; 2017; 37(5):531-538. PubMed ID: 28946966 [TBL] [Abstract][Full Text] [Related]
36. Coagulation parameters are associated with the prognosis of immunoglobulin a nephropathy: a retrospective study. Xia M; Liu D; Peng L; Li Y; Liu H; Wu L; Chen G; Liu Y; Liu H BMC Nephrol; 2020 Oct; 21(1):447. PubMed ID: 33109129 [TBL] [Abstract][Full Text] [Related]
37. Influences of renal anemia on the pathology of IgA nephropathy: a study based on propensity score matching. Li F; Wei RB; Wang Y; Su TY; Li QP; Li P; Chen XM Discov Med; 2020; 30(159):7-18. PubMed ID: 33357358 [TBL] [Abstract][Full Text] [Related]
38. [Effect of serum IgA/C3 and glomerular C3 staining on clinical prognosis in patients with IgA nephropathy]. Pei GQ; Qin AY; Wang SQ; Tan L; Tang Y; Qin W Zhonghua Yi Xue Za Zhi; 2020 Aug; 100(30):2372-2377. PubMed ID: 32791814 [No Abstract] [Full Text] [Related]
39. Automated Prediction of Kidney Failure in IgA Nephropathy with Deep Learning from Biopsy Images. Testa F; Fontana F; Pollastri F; Chester J; Leonelli M; Giaroni F; Gualtieri F; Bolelli F; Mancini E; Nordio M; Sacco P; Ligabue G; Giovanella S; Ferri M; Alfano G; Gesualdo L; Cimino S; Donati G; Grana C; Magistroni R Clin J Am Soc Nephrol; 2022 Sep; 17(9):1316-1324. PubMed ID: 35882505 [TBL] [Abstract][Full Text] [Related]
40. High serum and urine neutrophil gelatinase-associated lipocalin levels are independent predictors of renal progression in patients with immunoglobulin A nephropathy. Rhee H; Shin N; Shin MJ; Yang BY; Kim IY; Song SH; Lee DW; Lee SB; Kwak IS; Seong EY Korean J Intern Med; 2015 May; 30(3):354-61. PubMed ID: 25995666 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]